Cholecalciferol and Flu Vaccine in Treating Healthy Participants

Stopped early · Not applicable

Conditions studied: Healthy, no Evidence of Disease

In brief

This randomized clinical trial studies cholecalciferol and flu vaccine in treating healthy participants. Cholecalciferol may increase the immunologic response of flu vaccine in healthy participants. Flu vaccine may help the body build an immune response and help prevent flu

Key facts

Study ID

NCT01561989

Run by

Roswell Park Cancer Institute

People needed

11

Starts

2011-10-01

Expected to finish

2015-06-01

Last updated by the study team

2020-03-10

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy individuals seen at the Employee Health Clinic who will be eligible to receive influenza vaccine
• Willingness to comply with study expectations
• subject or legal representative must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
• INTERVENTION COMPONENT ONLY:
• Willing to suspend use of any other vitamin D supplementation during the 3 month treatment interval; if currently using > 2,000 IU/day of vitamin D supplementation, must suspend use 30 days prior to enrollment

You may not qualify if…

• not RPCI employee

Where it is running

• Roswell Park Cancer Institute — Buffalo, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.